On 2025-05-06, TScan Therapeutics, Inc. (TCRX) announced earnings per share of $-0.26 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.28.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.28 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.28 | $-0.26 |
| 2025-03-05 | 2024-12-31 | $-0.27 | $-0.29 |
| 2024-11-12 | 2024-09-30 | $-0.28 | $-0.25 |
| 2024-08-12 | 2024-06-30 | $-0.30 | $-0.28 |
| 2024-05-13 | 2024-03-31 | $-0.25 | $-0.32 |
| 2024-03-06 | 2023-12-31 | $-0.30 | $-0.21 |
| 2023-11-09 | 2023-09-30 | $-0.43 | $-0.24 |
| 2023-08-10 | 2023-06-30 | $-0.76 | $-0.51 |
| 2023-05-10 | 2023-03-31 | $-0.73 | $-0.93 |
| 2023-03-08 | 2022-12-31 | $-0.73 | $-0.78 |
| 2022-11-09 | 2022-09-30 | $-0.73 | $-0.67 |
| 2022-08-10 | 2022-06-30 | $-0.76 | $-0.63 |
| 2022-05-09 | 2022-03-31 | $-0.69 | $-0.67 |
| 2021-11-10 | 2021-09-30 | $-0.68 | $-0.80 |
| 2021-08-19 | 2021-06-30 | $-6.12 | $-7.69 |